ClinicalTrials.gov
ClinicalTrials.gov Menu

CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00038818
Recruitment Status : Terminated (Low accrual.)
First Posted : June 7, 2002
Last Update Posted : August 23, 2012
Sponsor:
Collaborator:
Eligix
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2002
  Actual Study Completion Date : December 2002